Novo Nordisk’s New Diabetes Combo Shows Potential To Best Lilly’s Mounjaro

Fierce Competition In Diabetes And Obesity Expected

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.